Human monocytic ehrlichiosis in a renal transplant patient.
Human ehrlichiosis is an emerging pathogen in immunocompromised patients, potentially leading to increased morbidity compared to immunocompetent patients. A high index of suspicion is imperative and early treatment with doxycycline can be life-saving. We report the case of an immunosuppressed renal transplant patient who was diagnosed with human monocytic ehrlichiosis and successfully treated with doxycycline.
Cotant
Casey
C
Department of Internal Medicine, Wilford Hall Medical Center, Lackland AFB, Texas 78236, USA.
Okulicz
Jason F
JF
Brezina
Barton
B
Riley
Daniel J
DJ
Conger
Nicholas G
NG
D004318:Doxycycline / Q000627:therapeutic use; D016873:Ehrlichiosis / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged
D004318:Doxycycline